IP Verse

Wise patent opposition analysis

The comprehensive analysis of Wise opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wise

Stay updated with the latest patent oppositions filed by Wise

Patent NumberTitleApplicantOpposition DateOpposition Company
EP1974014
Oligopeptide-Free Cell Culture MediaBAXTER HEALTHCAREJan 18, 2018CSL BEHRING GMBH
EP2329847
Use Of An Antibody Or An Immunotoxin That Selectively Binds To Cd123 To Impair Hematologic Cancer Progenitor CellsUNIVERSITY OF KENTUCKY RESEARCH FOUNDATIONAug 1, 2017CSL
EP2314285
Lipophilic Drug Delivery Vehicle And Methods Of Us ThereofCHILDRENS HOSPITAL & RESEARCH CENTER AT OAKLANDMay 3, 2017CSL
EP2357241
Collagen Producing Plants And Methods Of Generating And Using SameCOLLPLANTDec 4, 2015FIBROGEN, INC.
EP2510011
Monoclonal Antibodies That Bind B7H6 And Uses ThereofINSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEJun 17, 2015JAMES POOLE

Top clients of Wise

Top companies who are the clients of Wise

CompanyTotal
CSL2
CSL BEHRING GMBH1
FIBROGEN, INC.1
JAMES POOLE1